Who owns Neogene Therapeutics?

Neogene Therapeutics is formerly owned by Jeito Capital, through Jeito I, since 2020.

When did Jeito Capital acquire Neogene Therapeutics?

Jeito Capital acquired Neogene Therapeutics in 2020 and exited after 3 years.

Has Neogene Therapeutics been sold?

Yes. Neogene Therapeutics was exited in 2023 via Trade Sale.

Home/Companies/Biotech/Neogene Therapeutics

Neogene Therapeutics

Biotech·

Netherlands·Exited 2023·Held 3yr

Neogene Therapeutics is a healthcare company, headquartered in France.

Entry

2020

Hold

3yr

Exit

2023

Est. EV

–

Investor

Jeito Capital

Key facts

HQFrance

SectorHealthcare

Amsterdam-based cell therapy company developing T-cell receptor therapies for solid tumors; Jeito Capital backed 2020 and exited early 2023…Read full notes

See the full ownership history.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

Exit details: type, year, MOIC (buyer on Pro)

Start free

Already a member? Sign in

More from Jeito I

Other portfolio companies in the same fund.

Corteria Pharmaceuticals

More PE-backed in Biotech

Comparable biotech deals from other GPs.

AdBio PartnersBelgium

Last updated April 2026 · Sourced from public filings